Updated Sunday, 14 December 2025 (markets last closed Friday, 12 December 2025).
Imperial Brands PLC shares ended the week on the back foot after touching a fresh 52‑week high earlier in the week, with investors weighing a familiar mix for UK tobacco equities: steady capital returns (buybacks + dividends), debt housekeeping, and the slow pivot toward “next‑generation products” (NGP) while cigarette volumes drift lower.
As of the last close on Friday, 12 December, Imperial Brands (LSE: IMB) finished at 3,179p (£31.79). [1]
Below is what moved the stock in the last few sessions, what’s newly on the company tape, what analysts and technical indicators are implying right now, and what to watch in the week ahead (15–19 December 2025).
Imperial Brands share price recap: a 52‑week high, then three down days
Imperial Brands’ week had a very “tobacco stock” rhythm: grind higher, tag a new high, then cool off.
- Mon 8 Dec: closed 3,262p [2]
- Tue 9 Dec: closed 3,312p after printing an intraday 3,329p high (52‑week high area) [3]
- Wed 10 Dec: closed 3,283p [4]
- Thu 11 Dec: closed 3,265p [5]
- Fri 12 Dec: closed 3,179p, down 2.63% on the day [6]
That puts IMB down about 2.54% for the week (3,262p → 3,179p), even after the early‑week breakout. [7]
The 52‑week range shown on Investing.com is 2,521p to 3,329p, which matters because the stock is now only ~4–5% below the high—close enough that traders will treat 3,329p as the first big “prove it” resistance level. [8]
The biggest “new” company news in the last days: buybacks, annual report, and a bond redemption
1) Buybacks stayed busy all week (and they’re not subtle)
Imperial has been filing daily “Transaction in own shares” RNS updates, confirming ongoing repurchases under the £1.45 billion buyback programme.
In the five trading sessions from 8–12 December, Imperial disclosed the following buybacks for cancellation:
- 8 Dec:280,628 shares (avg 3,246.19p) [9]
- 9 Dec:114,050 shares (avg 3,279.60p) [10]
- 10 Dec:54,059 shares (avg 3,297.24p) [11]
- 11 Dec:214,880 shares (avg 3,280.80p) [12]
- 12 Dec:301,925 shares (avg 3,219.27p) [13]
Total for the week: 965,542 shares repurchased across those five sessions (based on the published RNS figures). [14]
Buybacks don’t guarantee a rising share price (Friday proved that), but they do create a persistent bid and mechanically reduce the share count—one reason tobacco names can look “sticky” even when the broader market is messy.
2) Annual Report + AGM notice landed (a governance/calendar catalyst)
On 11 December 2025, Imperial confirmed publication of its Annual Report and Accounts 2025 and that its Notice of AGM 2026 had been sent to shareholders. The AGM is scheduled for Wednesday, 28 January 2026 (9:30am) in Bristol. [15]
This isn’t typically a price-moving event on its own, but it matters for:
- Dividend approvals (final dividend is subject to shareholder approval), and
- The “what could management get grilled about?” factor (NGP progress, regulation, litigation, buyback strategy).
3) Debt housekeeping: Imperial Brands Finance to redeem €650m notes early
A separate but notable balance‑sheet item hit this week: Imperial Brands Finance PLC announced it will redeem €650 million 3.375% Guaranteed Notes on 30 December 2025, ahead of the original 26 February 2026 maturity date. Noteholders are set to receive 100% of principal plus accrued interest. [16]
For equity investors, early redemptions can be read two ways:
- Boring positive: reduces refinancing “noise,” keeps maturity walls tidy.
- Neutral: the cost/benefit depends on what that cash would otherwise do (buybacks, dividends, reinvestment).
A small governance headline: Director Declaration
Imperial also disclosed that Stefan Bomhard (executive director; former CEO) serves as a non‑executive director of The Magnum Ice Cream Company N.V., whose shares were admitted to listing on Euronext Amsterdam, the LSE, and the NYSE effective 8 December 2025. [17]
This is standard UK listing-rule disclosure rather than a strategic shift—but it is still “official company news” from the last days.
Fundamentals refresher: what the company last guided (and why it still frames the stock)
Even though this week’s headlines were mostly corporate plumbing (buybacks, report, debt), the stock’s medium‑term narrative is still anchored to FY25 results and FY26 guidance.
From the company’s FY25 results statement (published 18 November 2025), Imperial highlighted:
- Tobacco & NGP net revenue growth of 4.1% at constant currency [18]
- NGP net revenue up 13.7% (double‑digit growth) [19]
- Group adjusted operating profit growth (constant currency) alongside free cash flow of £2.7bn [20]
- FY25 dividend per share 160.32p, up 4.5%, and a shift to four equal quarterly dividends [21]
- Buybacks: FY25 £1.25bn completed and a £1.45bn buyback for FY26 commenced [22]
- FY26 outlook: adjusted operating profit expected to grow 3%–5% (constant currency), and FY26 free cash flow expected to be at least £2.2bn after “Strategy costs” [23]
Reuters’ coverage of the FY25 results also emphasized that Imperial slightly exceeded profit expectations and reiterated its push into smoking alternatives while maintaining strong shareholder returns. [24]
Dividend timing: what’s next on the calendar
Imperial’s dividend schedule is unusually relevant right now because one payment is close:
- Third interim dividend:40.08p, paid 31 December 2025 (ex‑date 27 Nov 2025) [25]
- AGM:28 January 2026 [26]
- Final dividend (subject to approval): ex‑date 19 Feb 2026, payment 31 Mar 2026 [27]
At the current share price area (3,179p), the FY25 full-year dividend (160.32p) implies a rough trailing yield around ~5% (simple dividend/price math; not a forward guarantee). [28]
Forecasts and analyst views: targets cluster around mid‑3,500s pence, with a wide range
Analyst target prices vary by source, but they cluster in the same neighborhood:
- MarketBeat (5 analysts): consensus price target 3,562.50p, with high 4,200p and low 2,700p; consensus rating listed as “Moderate Buy.” [29]
- TradingView: analyst price target 3,525p, max 4,200p, min 2,700p. [30]
Company-hosted consensus estimates (numbers, not price targets)
Imperial publishes a “consensus estimates” table based on analyst projections (dated 05 November 2025). It includes operational and earnings forecasts such as:
- FY26 Tobacco & NGP net revenue: £8,368m
- FY26 NGP revenues: £426m
- FY26 Total group adjusted operating profit: £4,120m
- FY26 Adjusted EPS: 343.5p
- Constant currency growth assumptions: FY26 2.3% net revenue and 3.9% adjusted operating profit (YoY). [31]
This matters because it frames what “meeting expectations” could look like before the next major results cycle.
Technical analysis snapshot: oversold signals flash, but longer-term trend still points up
If you like technicals, Imperial’s chart is currently doing a classic thing: strong longer‑term trend, short‑term pullback.
Investing.com’s technical dashboard (as of the 12 Dec close) showed:
- RSI(14): 19.81 (“Oversold”) [32]
- Multiple oscillators flagged oversold/weak momentum (e.g., Williams %R, Ultimate Oscillator) [33]
- Moving averages (MA5 through MA200) were broadly marked “Sell” on that daily snapshot [34]
- Yet the weekly and monthly summary on the same page still read “Strong Buy.” [35]
Translation into normal human: the pullback has been sharp enough to trip “oversold” alarms, but the multi‑month uptrend hasn’t been invalidated just because the last three sessions were red.
Levels to watch (common trader framing):
- Resistance: the 3,320–3,329p zone (this week’s highs / 52‑week high area). [36]
- Support: the 3,170–3,160p region shows up in multiple pivot frameworks on the Investing.com page (and it’s close to Friday’s low). [37]
Technical levels are not destiny; they’re just where a lot of attention tends to cluster.
Industry and regulation backdrop: why “vapes” can still move tobacco stocks
Imperial’s investment case still leans heavily on combustibles cash flows, but the NGP trajectory matters for the multiple investors are willing to pay.
One UK datapoint making headlines: a UK crackdown on single‑use devices has been linked to a drop in vape retail spending over the year to early September 2025, according to NIQ/The Grocer data cited by The Times. [38]
Imperial’s own FY25 commentary pointed to Europe’s vapour market transitioning toward reusable formats, with blu positioned accordingly in certain markets. [39]
Zooming out, the sector is also watching how regulators address illicit and unregulated products—particularly in the U.S. vape market, where competition dynamics have been a stated headwind for rivals. [40]
Week ahead (15–19 Dec 2025): what to watch for IMB shares
1) More buyback RNS updates (the steady drumbeat)
Given the pace this week, the market will likely keep seeing near‑daily repurchase updates while the £1.45bn programme continues. [41]
Even when price is falling, those announcements can shape sentiment (“support is still on”).
2) “Oversold bounce” vs. “failed breakout” debate
Technicals currently show a near-term oversold picture (RSI < 20 on a daily basis) while the price is still close to its high. [42]
That’s exactly the setup where traders split into two tribes:
- Bounce hunters: look for mean reversion back toward 3,230–3,260p.
- Breakout skeptics: argue the stock just printed a high and is now rolling over, so rallies get sold.
3) Calendar proximity: dividend payment and bond redemption are approaching (not next week, but soon)
Two “known dates” are close enough to stay on radar:
- 30 Dec 2025: planned redemption of the €650m notes [43]
- 31 Dec 2025:third interim dividend payment [44]
Neither is an earnings event, but both reinforce the capital-returns / balance-sheet narrative.
4) Macro tone: defensive stocks can still wobble
Imperial often trades like a defensive, cash-return story inside the FTSE 100, but Friday showed it can still underperform in a weak session. [45]
So next week, broad risk appetite (rates, FX, index flows) can matter even without Imperial-specific news.
Risks investors are actively pricing (and why they matter next week too)
A quick reality check: tobacco stocks can look serene right up until regulation or litigation enters the chat wearing steel-toed boots.
Key risk buckets that can reprice sentiment quickly:
- Regulatory tightening (tobacco duty, packaging rules, flavour limits, vape product restrictions, enforcement against illicit supply). [46]
- NGP execution risk (share and profitability in vapour/oral/heated formats versus larger peers). [47]
- Balance-sheet/capital allocation trade-offs (how much goes to buybacks vs. debt vs. investment). [48]
Bottom line for the week ahead
Imperial Brands enters the new week with three big forces tugging on the tape:
- Mechanical support from buybacks (nearly a million shares repurchased in the last five sessions, per RNS disclosures), [49]
- A short-term pullback after a 52‑week high (and “oversold” technical readings showing up), [50]
- A steady fundamentals narrative anchored in FY26 guidance (3%–5% adjusted operating profit growth) and an investor calendar featuring the 31 Dec dividend payment and 28 Jan AGM. [51]
No single headline screams “new strategic turn” this week—but the combined message is very consistent: Imperial is still running the shareholder-returns playbook hard, while markets decide how much they trust the NGP growth arc and how much they fear the regulatory arc.
References
1. www.investing.com, 2. www.investing.com, 3. www.investing.com, 4. www.investing.com, 5. www.investing.com, 6. www.investing.com, 7. www.investing.com, 8. www.investing.com, 9. www.investegate.co.uk, 10. www.investegate.co.uk, 11. www.investegate.co.uk, 12. markets.ft.com, 13. www.investegate.co.uk, 14. www.investegate.co.uk, 15. www.investegate.co.uk, 16. www.investing.com, 17. markets-data-api-proxy.ft.com, 18. www.imperialbrandsplc.com, 19. www.imperialbrandsplc.com, 20. www.imperialbrandsplc.com, 21. www.imperialbrandsplc.com, 22. www.imperialbrandsplc.com, 23. www.imperialbrandsplc.com, 24. www.reuters.com, 25. www.imperialbrandsplc.com, 26. www.imperialbrandsplc.com, 27. www.imperialbrandsplc.com, 28. www.imperialbrandsplc.com, 29. www.marketbeat.com, 30. www.tradingview.com, 31. www.imperialbrandsplc.com, 32. www.investing.com, 33. www.investing.com, 34. www.investing.com, 35. www.investing.com, 36. www.investing.com, 37. www.investing.com, 38. www.thetimes.com, 39. www.imperialbrandsplc.com, 40. www.reuters.com, 41. www.investegate.co.uk, 42. www.investing.com, 43. www.investing.com, 44. www.imperialbrandsplc.com, 45. www.marketwatch.com, 46. www.thetimes.com, 47. www.imperialbrandsplc.com, 48. www.imperialbrandsplc.com, 49. www.investegate.co.uk, 50. www.investing.com, 51. www.imperialbrandsplc.com
